Uncategorized
Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, the Company’s Chief Executive Officer, will be participating in and presenting at the H.C. Wainwright & Co. Inc. Virtual Ophthalmology Conference. Mr. Culley’s presentation will be available on-demand starting on August 17th, 2021 at 7am ET / 4am PT. Mr. Cu